SEC Form 3 · accession 0001209191-18-033114
Iterum Therapeutics plc · ITRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey R. Schaffnit
Officer — Chief Commercial Officer
Period of report
May 24, 2018
Accepted (ET)
May 24, 2018 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659323
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are beneficially owned. | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.